| Statin use does not reduce risk of acute kidney injury following cardiac surgery |
| Abbott initiates voluntary MitraClip delivery system safety notice |
| AHA enacts tougher anti-smoking policy for cities hosting its conferences |
| Women have lower one-year mortality rates after TAVR with the Sapien valve |
| Most FDA-approved high-risk cardiovascular device studies are published in peer-reviewed literature |
| As FDA commissioner, Califf plans on focusing on evidence-based medicine |
| ACC releases lifelong learning competencies document for cardiologists |
| Physicians preach caution when interpreting and implementing SPRINT trial results |
| Boston Scientific chairman and co-founder to retire in May; CEO will replace him |
| Senate confirms Califf as FDA commissioner |
| FDA approves Boston Scientific’s quadripolar leads |
| Death rates associated with in-hospital cardiogenic shock following acute MI decline in recent years |
| FDA rejects expanded indications for Merck cholesterol drugs |
| High-dose tirofiban during PCI is associated with significant reduction in all-cause mortality |
| Stenting and endarterectomy have similar outcomes in asymptomatic patients with severe carotid stenosis |
| After stroke, Pioglitazone reduces risk of MI or subsequent stroke |
| Neurological improvement following strokes may still lead to unfavorable outcomes |
| Boston Scientific Receives CE Mark For Eluvia™ Drug-Eluting Vascular Stent and Announces Initiation of New Clinical Trial |
| Medtronic Receives CE Mark for Full Line of Cardiac Resynchronization Therapy-Defibrillators Compatible with MRI Scans |
| Untreated hypertension leads to increased risk of intracerebral hemorrhage |
| Hospital reimbursement for alteplase does not match up with increased costs |
| DOJ reaches settlements with 51 hospitals for allegedly improperly implanting ICDs |
| Therox Enrolls First Patient in Study of Next-Generation Supersaturated Oxygen Therapy for Ami |
| Medtronic increases cash dividend 25 percent for fiscal year’s fourth quarter |
| FDA approves St. Jude Medical’s pacing technology, leads and quartet test |
| Mended Hearts launches LVAD video contest |
| Stryker agrees to acquire Physio-Control for $1.28 billion |
| ACC, AHA express concern with conflicting blood pressure measure sets |
| Stroke researchers and scientists receive national awards |
| International stroke conference features more than 1,500 presentations |
| Nearly 17 million U.S. adults may benefit from lowering systolic blood pressure goal |
| Paris Cardiology Center Improves Cath Lab Offering with Toshiba’s Cardiovascular X-ray |
| Senate plans on holding a procedural vote on Califf’s nomination for FDA commissioner |
| Model finds the CardioMEMS device is cost-effective for heart failure patients |
| Harvard researchers examine PCI readmission metric |
| Cook Medical voluntarily recalls catheters, pressure monitoring sets and trays |
| Software Leaders Collaborate to Develop Powerful Cardiovascular EHR System |
| IBHRE Promotes Certification among Heart Rhythm Examiners |
| CMS decision may expand use of Watchman device in the U.S. |
| Contrary to popular perception, inpatient echo may not be used enough |
| ACC announces late-breaking clinical trials for annual scientific session |
| Hospital ratings at a glance |
| Novartis agrees to pay-for-performance agreements with insurers to cover heart failure drug |
| CMS releases national coverage determination for Watchman and other LAA devices |
| New Real-World Comparison Showing Similar Efficacy Between the Lutonix® and In.Pact™ Drug-Coated Balloons Featured at LINC 2016 |
| TAVR procedure saves Selma’s first black police chief |
| Abiomed’s quarterly revenue increases 38% |
| Prices of pacemakers, defibrillators and other devices are declining |
| FDA grants Spectranetics bridge occlusion balloon 510(k) clearance |
| Spectranetics Receives FDA 510(k) Clearance for Bridge™ Occlusion Balloon for Lead Extraction Procedures |
| FDA approves Medtronic's MRI conditional CRT defibrillators for heart failure patients |
| Edwards Lifesciences agrees to repurchase $325 million of its common stock |
| Boston Scientific’s revenue and earnings per share increase in Q4 |
| Merit Medical acquires vascular access system for $18.5 million |
| Endologix, Inc. and TriVascular Technologies, Inc. Complete Merger |
| Text messaging interventions may improve medication adherence |
| Edwards Lifesciences’ TAVR sales increase 25 percent in fourth quarter |
| Pediatric hospital stops conducting elective heart surgeries pending internal review |
| Abbott acquires Kalila Medical, expands heart rhythm disorder portfolio |
| Trial results show mortality rates following TAVR decreased over time |
| Medtronic acquires privately held company to expand renal care business |
| University Medical Center New Orleans Implements Stereotaxis Platform for Advanced Treatment of Cardiac Arrhythmias |
| Seven researchers receive nearly $800,000 to examine congenital heart defect |
| Most U.S. adults do not know exercise guidelines for preventing heart disease |
| Sales of MitraClip device increase in Q4 |
